<DOC>
	<DOCNO>NCT00899353</DOCNO>
	<brief_summary>Escalating dos Omega 3 Fatty Acids use patient early stage Chronic Lymphocytic Leukemia ( ES-CLL ) , Monoclonal Gammopathy Undetermined Significance ( MGUS ) , Smoldering Multiple Myeloma ( SMM ) , whose disease currently require treatment . The primary aim study determine Omega 3 supplementation help prevent delay progression disease stage require treatment .</brief_summary>
	<brief_title>Prevention Disease Progression Early Stage Indolent B Cell Malignancies . ( SMM )</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Paraproteinemias</mesh_term>
	<mesh_term>Monoclonal Gammopathy Undetermined Significance</mesh_term>
	<criteria>Must 18 year age . Must free medical condition would decrease life expectancy le 12 month . Must free Omega 3 supplement fish oil contain nutritional supplement minimum two month prior enrollment . Must ECOG performance status 0,1 2 . Any lifethreatening condition ( limited ) advance heart disease , kidney liver failure expect survival le 12 month . Any active malignancy . Women pregnant lactating . Individuals unable give inform consent . Individuals know allergy intolerance fish oil supplement . Any patient active bleeding diatheses disorder . ECOG performance status 3 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>ES-CLL</keyword>
	<keyword>MGUS</keyword>
	<keyword>SMM</keyword>
	<keyword>Early Stage - Chronic Lymphocytic Leukemia</keyword>
</DOC>